Lataa...
WT1基因在急性髓系白血病微小残留病监测中的应用
OBJECTIVE: To probe the potential utility of Wilms tumor 1 (WT1) as a marker of minimal residual disease (MRD) in acute myeloid leukemia (AML) to estimate the relapse-predicting cut-off value. METHODS: Quantitative assessment of bone marrow WT1 mRNA level was preformed using real-time quantitative r...
Tallennettuna:
| Julkaisussa: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Editorial office of Chinese Journal of Hematology
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7348239/ https://ncbi.nlm.nih.gov/pubmed/28954349 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.08.009 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|